Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jane Devane"'
Autor:
Michelle Marie Lockhart, Holger Weis, Donna Tunnicliff, Sarah Harland, Borje Darpo, Jane Devane, R. S. Crockett, Gavin Cape, John Howes, C. Tak Hung, Meijian Zhou, Lawrence Friedhoff, Noelyn Hung, Fred Lam, Paul Glue
Publikováno v:
Clinical Pharmacology in Drug Development. 5:460-468
Ibogaine is a psychoactive substance that may reduce opioid withdrawal symptoms. This was the first clinical trial of noribogaine, ibogaine's active metabolite, in patients established on methadone opioid substitution therapy (OST). In this randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d307c2c1237945aa226f0b88e893451a
https://doi.org/10.1002/cpdd.254
https://doi.org/10.1002/cpdd.254
Autor:
C. Tak Hung, Fred Lam, Noelyn Hung, Gavin Cape, John Howes, Michelle Marie Lockhart, Lawrence Friedhoff, Sarah Harland, Paul Glue, Jane Devane, Holger Weis, Donna Tunnicliff, Andrew R. Gray
Publikováno v:
The Journal of Clinical Pharmacology. 56:960-965
The aim of this study was to switch patients established on methadone opioid substitution therapy (OST) to morphine over 1 week. Subjects established on daily methadone OST (mean dose 60 mg/day) were switched to morphine slow-release capsules, dosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96dfcf6256f8a8405fee5bc741d581f9
https://doi.org/10.1002/jcph.704
https://doi.org/10.1002/jcph.704
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionHealthcare-associated infections (HCAIs) associated with extended-spectrum cephalosporin-resistant gram-negative (ESC-R GN) bacteria are an emerging concern in veterinary hospitals, especially in companion animal intensive care units (ICU
Externí odkaz:
https://doaj.org/article/c148b62bd8654a7c9f5fffb24b38b3e2
Autor:
Paul, Glue, Gavin, Cape, Donna, Tunnicliff, Michelle, Lockhart, Fred, Lam, Noelyn, Hung, C Tak, Hung, Sarah, Harland, Jane, Devane, R S, Crockett, John, Howes, Borje, Darpo, Meijian, Zhou, Holger, Weis, Lawrence, Friedhoff
Publikováno v:
Clinical pharmacology in drug development. 5(6)
Ibogaine is a psychoactive substance that may reduce opioid withdrawal symptoms. This was the first clinical trial of noribogaine, ibogaine's active metabolite, in patients established on methadone opioid substitution therapy (OST). In this randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9118ba2bcaa394fb681bac4cf81e90ed
https://pubmed.ncbi.nlm.nih.gov/27870477
https://pubmed.ncbi.nlm.nih.gov/27870477